New and emerging priorities for global healthCardiometabolic risk factors in Human Immunodeficiency Virus infected patients on 2nd line anti-retroviral therapy in Nairobi, KenyaAuthorsDas AnukaMugisha NancyTutak StephanieKiio StephenKwatampora LilyKeiser PhilipAchieng LoiceYear: 2016Volume: 82 Issue: 3Page/Article: 412DOI: 10.1016/j.aogh.2016.04.150Published on Aug 20, 2016Peer ReviewedCC BY 4.0